Jonathan Yong
Stock Analyst at UBS
(2.65)
# 2,006
Out of 5,116 analysts
95
Total ratings
61.11%
Success rate
11.82%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Neutral | $12 → $17 | $14.35 | +18.47% | 10 | Jan 9, 2026 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $2.83 | +76.68% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.24 | +33.93% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $10.63 | +12.89% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.27 | +252.42% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $9.32 | +178.97% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $27.09 | -48.32% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $75.48 | +27.19% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $15.05 | +112.62% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $21.30 | +392.96% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $94.53 | -15.37% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $271.52 | -14.92% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $5.45 | +395.41% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $214.88 | -53.46% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $831.21 | -45.86% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $2.32 | +417.24% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $4.55 | +1,438.46% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $18.81 | -9.62% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $179.59 | +94.89% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $13.44 | +606.85% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $2.16 | +293.52% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $23.22 | +76.57% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.21 | +164.80% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $80.43 | +5.68% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $187.03 | -21.94% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $43.32 | +144.69% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $201.26 | -21.99% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $274.11 | +34.25% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $195.20 | +225.31% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $74.52 | +57.00% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $21.38 | +40.32% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $488.27 | -38.97% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $189.28 | -49.81% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $286.93 | +72.52% | 1 | Oct 15, 2021 |
Oscar Health
Jan 9, 2026
Upgrades: Neutral
Price Target: $12 → $17
Current: $14.35
Upside: +18.47%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $2.83
Upside: +76.68%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.24
Upside: +33.93%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $10.63
Upside: +12.89%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.27
Upside: +252.42%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $9.32
Upside: +178.97%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $27.09
Upside: -48.32%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $75.48
Upside: +27.19%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $15.05
Upside: +112.62%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $21.30
Upside: +392.96%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $94.53
Upside: -15.37%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $271.52
Upside: -14.92%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $5.45
Upside: +395.41%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $214.88
Upside: -53.46%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $831.21
Upside: -45.86%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $2.32
Upside: +417.24%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $4.55
Upside: +1,438.46%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $18.81
Upside: -9.62%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $179.59
Upside: +94.89%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $13.44
Upside: +606.85%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $2.16
Upside: +293.52%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $23.22
Upside: +76.57%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.21
Upside: +164.80%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $80.43
Upside: +5.68%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $187.03
Upside: -21.94%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $43.32
Upside: +144.69%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $201.26
Upside: -21.99%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $274.11
Upside: +34.25%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $195.20
Upside: +225.31%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $74.52
Upside: +57.00%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $21.38
Upside: +40.32%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $488.27
Upside: -38.97%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $189.28
Upside: -49.81%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $286.93
Upside: +72.52%